Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

  • Post by:
  • 23 May 2019
  • Comments off
Categories:

Participating Institutions

The University of Queensland
The University of Sydney
Australian National University
Monash University
Queensland University of Technology
Edith Cowan University
CSIRO

International Partners

Boston Children’s Hospital, Harvard
University of Washington
University of Tokyo
Massachusetts Institute of Technology
University of Illinois at Urbana-Champaign
University of Southampton

Twitter
YouTube